Planning

2025+ COVID-19 Vaccine Procurement

UKHSA

This public procurement record has 1 release in its history.

Planning

17 Nov 2023 at 16:45

Market Engagement Notice
Summary of the contracting process

The UK Health Security Agency (UKHSA) is planning the "2025+ COVID-19 Vaccine Procurement" tender. The procurement process is currently in the planning stage, with key milestones including the engagement end date on 5th January 2024. The objective is to establish a flexible procurement model to meet future COVID-19 vaccine demand requirements, matching supply to the planned vaccination programme needs and exploring new vaccine technologies. The UKHSA is located at 10 South Colonnade, London, E14 4PU, United Kingdom. The industry category for this procurement is Vaccines.

This tender presents an opportunity for suppliers involved in COVID-19 vaccine production or development. Small and medium-sized enterprises (SMEs) with capabilities to supply COVID-19 vaccines are encouraged to participate. The procurement strategy will be updated based on market engagement feedback, with the procurement opportunity expected to be advertised in Q2 2024. Suppliers can engage through the Atamis eTendering system to access the market engagement questionnaire. The response window will close at 5pm on Friday 5 January 2024. 1:1 meetings with the project team may be requested post-questionnaire completion.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

2025+ COVID-19 Vaccine Procurement

Notice Description

UK Health Security Agency is inviting suppliers to participate in a market engagement activity to help inform and shape our approach to the future procurement of COVID-19 vaccines. During the pandemic, contracts were agreed with a number of suppliers to meet the need for urgency and high volume of vaccines required to protect the population. These contracts come to an end in 2024 and as we move into an endemic phase of the disease, we are considering how best to meet our vaccine demand requirements in the future. The objective of future procurements will be to match supply to the particular requirements of the planned vaccination programme at the time, such as the current variant(s) of concern as well as the size and scope of eligible vaccination cohorts. We are also keen to ensure that we maintain access to any new and emerging vaccine technologies and developments in order to deliver the best outcomes from our immunisation programmes. As such, we are looking to establish a flexible procurement model that provides an efficient route to market and can adapt according to need. The purpose of this market engagement activity is to; * Understand both supplier appetite for participating in future COVID-19 vaccine procurements as well as current or planned supplier capability to supply COVID-19 vaccines. * Share our initial thoughts as to what the procurement approach may look like and test our assumptions and proposals. * Explore any potential barriers or concerns that there may be with the proposed approach to the market. The market engagement will take the form of a questionnaire available via our e-procurement system, (https://atamis-1928.my.site.com/s/Welcome). Once completed you will also have an opportunity to request a 1:1 meeting with the project team to discuss your answers and the project in more detail. It is anticipated that these meetings will take place during December 2023 and January 2024. Who would we like to hear from? We are keen to engage with those suppliers who may already have a COVID-19 vaccine approved or who have a vaccine in development that may be available within the timeframe of a future procurement. Next steps: Following this market engagement activity the team will review the feedback and use this to update and finalise the procurement strategy. We expect to advertise the procurement opportunity in Q2 2024, although all timings are subject to change. This PIN is being published for information purposes only to notify suppliers of a market engagement opportunity which relates to a potential procurement that will be set out in a future notice. UKHSA is still in the planning phase of this procurement. All information set out in this PIN could be subject to change. UKHSA is not liable for any costs incurred by potential suppliers in responding to this market engagement and reserves the right to cancel or terminate the engagement activity at any time. Additional information: The opportunity will be available on the Atamis eTendering system, access here: https://atamis-1928.my.site.com/s/Welcome . If you do not already have an account you can easily register for one via the same link. You will then be able to search for this opportunity and access the questionnaire and any other related documents. Please note that all correspondence must be conducted through the Atamis system. The response window will close at 5pm on Friday 5 January 2024. Access to the opportunity and all responses must be managed via the Atamis eprocurement system. 1:1 meetings will only be considered from those who have completed and returned the market engagement questionnaire. Depending on the level of response to the PIN, UKHSA may not be able to accommodate all meeting requests. If you need further assistance using the Atamis system please consult the online help or contact the help desk.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-52e84792-d717-4a07-b689-a5d670fd00e2
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/a6cc64ea-b920-481e-a46d-a0db505ec6ba
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Market Engagement Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
17 Nov 20232 years ago
Submission Deadline
Not specified
Future Notice Date
5 Jan 2024Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UKHSA
Contact Name
Covid Vaccine Unit, UKHSA
Contact Email
cvu.procurement@ukhsa.gov.uk
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-52e84792-d717-4a07-b689-a5d670fd00e2-2023-11-17T16:45:08Z",
    "date": "2023-11-17T16:45:08Z",
    "ocid": "ocds-b5fd17-52e84792-d717-4a07-b689-a5d670fd00e2",
    "language": "en",
    "initiationType": "tender",
    "title": "2025+ COVID-19 Vaccine Procurement",
    "planning": {
        "milestones": [
            {
                "id": "1",
                "title": "Engagement end date",
                "type": "engagement",
                "dueDate": "2024-01-05T23:59:59Z"
            }
        ],
        "documents": [
            {
                "id": "1",
                "documentType": "marketEngagementNotice",
                "description": "Early engagement notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/a6cc64ea-b920-481e-a46d-a0db505ec6ba",
                "datePublished": "2023-11-17T16:45:08Z",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "tender": {
        "id": "CF-2017800D0O000000rwimUAA",
        "title": "2025+ COVID-19 Vaccine Procurement",
        "description": "UK Health Security Agency is inviting suppliers to participate in a market engagement activity to help inform and shape our approach to the future procurement of COVID-19 vaccines. During the pandemic, contracts were agreed with a number of suppliers to meet the need for urgency and high volume of vaccines required to protect the population. These contracts come to an end in 2024 and as we move into an endemic phase of the disease, we are considering how best to meet our vaccine demand requirements in the future. The objective of future procurements will be to match supply to the particular requirements of the planned vaccination programme at the time, such as the current variant(s) of concern as well as the size and scope of eligible vaccination cohorts. We are also keen to ensure that we maintain access to any new and emerging vaccine technologies and developments in order to deliver the best outcomes from our immunisation programmes. As such, we are looking to establish a flexible procurement model that provides an efficient route to market and can adapt according to need. The purpose of this market engagement activity is to; * Understand both supplier appetite for participating in future COVID-19 vaccine procurements as well as current or planned supplier capability to supply COVID-19 vaccines. * Share our initial thoughts as to what the procurement approach may look like and test our assumptions and proposals. * Explore any potential barriers or concerns that there may be with the proposed approach to the market. The market engagement will take the form of a questionnaire available via our e-procurement system, (https://atamis-1928.my.site.com/s/Welcome). Once completed you will also have an opportunity to request a 1:1 meeting with the project team to discuss your answers and the project in more detail. It is anticipated that these meetings will take place during December 2023 and January 2024. Who would we like to hear from? We are keen to engage with those suppliers who may already have a COVID-19 vaccine approved or who have a vaccine in development that may be available within the timeframe of a future procurement. Next steps: Following this market engagement activity the team will review the feedback and use this to update and finalise the procurement strategy. We expect to advertise the procurement opportunity in Q2 2024, although all timings are subject to change. This PIN is being published for information purposes only to notify suppliers of a market engagement opportunity which relates to a potential procurement that will be set out in a future notice. UKHSA is still in the planning phase of this procurement. All information set out in this PIN could be subject to change. UKHSA is not liable for any costs incurred by potential suppliers in responding to this market engagement and reserves the right to cancel or terminate the engagement activity at any time. Additional information: The opportunity will be available on the Atamis eTendering system, access here: https://atamis-1928.my.site.com/s/Welcome . If you do not already have an account you can easily register for one via the same link. You will then be able to search for this opportunity and access the questionnaire and any other related documents. Please note that all correspondence must be conducted through the Atamis system. The response window will close at 5pm on Friday 5 January 2024. Access to the opportunity and all responses must be managed via the Atamis eprocurement system. 1:1 meetings will only be considered from those who have completed and returned the market engagement questionnaire. Depending on the level of response to the PIN, UKHSA may not be able to accommodate all meeting requests. If you need further assistance using the Atamis system please consult the online help or contact the help desk.",
        "status": "planning",
        "classification": {
            "scheme": "CPV",
            "id": "33651600",
            "description": "Vaccines"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "E14 4PU"
                    },
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-259891",
            "name": "UKHSA",
            "identifier": {
                "legalName": "UKHSA"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Covid Vaccine Unit, UKHSA",
                "email": "CVU.procurement@ukhsa.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-259891",
        "name": "UKHSA"
    }
}